Global Orally Disintegrating Tablet Excipient Market Research Report 2020

Publisher Name :
Date: 21-Jan-2020
No. of pages: 123
Inquire Before Buying

The global Orally Disintegrating Tablet Excipient market is valued at 15720 million US$ in 2020 is expected to reach 20060 million US$ by the end of 2026, growing at a CAGR of 3.5% during 2021-2026.

This report focuses on Orally Disintegrating Tablet Excipient volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Orally Disintegrating Tablet Excipient market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Orally Disintegrating Tablet Excipient market is segmented into

- Binders

- Glidents

- Diluents

- Disintegrants

- Others

- Binders had the biggest market share of 37% in 2018.

Segment by Application

- Anti-Psychotics Drug

- Anti-Epileptics Drug

- Others

- Anti-Epileptics Drug is the greatest segment of Orally Disintegrating Tablet Excipient application, with a share of 37% in 2018.

Global Orally Disintegrating Tablet Excipient Market: Regional Analysis

The Orally Disintegrating Tablet Excipient market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Orally Disintegrating Tablet Excipient market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Orally Disintegrating Tablet Excipient Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Orally Disintegrating Tablet Excipient market include:

- BASF

- JRS Pharma

- Roquette

- ABF Ingredients

- DFE Pharma

- Evonik

- Merck KGaA

- Ashland

- Meggle Pharma

- Shin-Etsu

- Fuji Chemical Industries

- McePharma (Vivesa holding)

- Cargill Incorporated

- Daicel Corporation

- Anhui Sunhere Pharmaceutical

Global Orally Disintegrating Tablet Excipient Market Research Report 2020

Table of Contents
1 Orally Disintegrating Tablet Excipient Market Overview
1.1 Product Overview and Scope of Orally Disintegrating Tablet Excipient
1.2 Orally Disintegrating Tablet Excipient Segment by Type
1.2.1 Global Orally Disintegrating Tablet Excipient Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Binders
1.2.3 Glidents
1.2.4 Diluents
1.2.5 Disintegrants
1.2.6 Others
1.3 Orally Disintegrating Tablet Excipient Segment by Application
1.3.1 Orally Disintegrating Tablet Excipient Sales Comparison by Application: 2020 VS 2026
1.3.2 Anti-Psychotics Drug
1.3.3 Anti-Epileptics Drug
1.3.4 Others
1.4 Global Orally Disintegrating Tablet Excipient Market Size Estimates and Forecasts
1.4.1 Global Orally Disintegrating Tablet Excipient Revenue 2015-2026
1.4.2 Global Orally Disintegrating Tablet Excipient Sales 2015-2026
1.4.3 Orally Disintegrating Tablet Excipient Market Size by Region: 2020 Versus 2026
2 Global Orally Disintegrating Tablet Excipient Market Competition by Manufacturers
2.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers (2015-2020)
2.2 Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers (2015-2020)
2.3 Global Orally Disintegrating Tablet Excipient Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Orally Disintegrating Tablet Excipient Manufacturing Sites, Area Served, Product Type
2.5 Orally Disintegrating Tablet Excipient Market Competitive Situation and Trends
2.5.1 Orally Disintegrating Tablet Excipient Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Orally Disintegrating Tablet Excipient Players (Opinion Leaders)
3 Orally Disintegrating Tablet Excipient Retrospective Market Scenario by Region
3.1 Global Orally Disintegrating Tablet Excipient Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Orally Disintegrating Tablet Excipient Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.3.1 North America Orally Disintegrating Tablet Excipient Sales by Country
3.3.2 North America Orally Disintegrating Tablet Excipient Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.4.1 Europe Orally Disintegrating Tablet Excipient Sales by Country
3.4.2 Europe Orally Disintegrating Tablet Excipient Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Orally Disintegrating Tablet Excipient Market Facts & Figures by Region
3.5.1 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region
3.5.2 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.6.1 Latin America Orally Disintegrating Tablet Excipient Sales by Country
3.6.2 Latin America Orally Disintegrating Tablet Excipient Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.7.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country
3.7.2 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Orally Disintegrating Tablet Excipient Historic Market Analysis by Type
4.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2015-2020)
4.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2015-2020)
4.3 Global Orally Disintegrating Tablet Excipient Price Market Share by Type (2015-2020)
4.4 Global Orally Disintegrating Tablet Excipient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Orally Disintegrating Tablet Excipient Historic Market Analysis by Application
5.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2015-2020)
5.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2015-2020)
5.3 Global Orally Disintegrating Tablet Excipient Price by Application (2015-2020)
6 Company Profiles and Key Figures in Orally Disintegrating Tablet Excipient Business
6.1 BASF
6.1.1 Corporation Information
6.1.2 BASF Description, Business Overview and Total Revenue
6.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.1.4 BASF Products Offered
6.1.5 BASF Recent Development
6.2 JRS Pharma
6.2.1 JRS Pharma Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.2.2 JRS Pharma Description, Business Overview and Total Revenue
6.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.2.4 JRS Pharma Products Offered
6.2.5 JRS Pharma Recent Development
6.3 Roquette
6.3.1 Roquette Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.3.2 Roquette Description, Business Overview and Total Revenue
6.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Roquette Products Offered
6.3.5 Roquette Recent Development
6.4 ABF Ingredients
6.4.1 ABF Ingredients Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.4.2 ABF Ingredients Description, Business Overview and Total Revenue
6.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.4.4 ABF Ingredients Products Offered
6.4.5 ABF Ingredients Recent Development
6.5 DFE Pharma
6.5.1 DFE Pharma Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.5.2 DFE Pharma Description, Business Overview and Total Revenue
6.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.5.4 DFE Pharma Products Offered
6.5.5 DFE Pharma Recent Development
6.6 Evonik
6.6.1 Evonik Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.6.2 Evonik Description, Business Overview and Total Revenue
6.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Evonik Products Offered
6.6.5 Evonik Recent Development
6.7 Merck KGaA
6.6.1 Merck KGaA Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.6.2 Merck KGaA Description, Business Overview and Total Revenue
6.6.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merck KGaA Products Offered
6.7.5 Merck KGaA Recent Development
6.8 Ashland
6.8.1 Ashland Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.8.2 Ashland Description, Business Overview and Total Revenue
6.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Ashland Products Offered
6.8.5 Ashland Recent Development
6.9 Meggle Pharma
6.9.1 Meggle Pharma Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.9.2 Meggle Pharma Description, Business Overview and Total Revenue
6.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Meggle Pharma Products Offered
6.9.5 Meggle Pharma Recent Development
6.10 Shin-Etsu
6.10.1 Shin-Etsu Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.10.2 Shin-Etsu Description, Business Overview and Total Revenue
6.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Shin-Etsu Products Offered
6.10.5 Shin-Etsu Recent Development
6.11 Fuji Chemical Industries
6.11.1 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.11.2 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Description, Business Overview and Total Revenue
6.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Fuji Chemical Industries Products Offered
6.11.5 Fuji Chemical Industries Recent Development
6.12 McePharma (Vivesa holding)
6.12.1 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.12.2 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Description, Business Overview and Total Revenue
6.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.12.4 McePharma (Vivesa holding) Products Offered
6.12.5 McePharma (Vivesa holding) Recent Development
6.13 Cargill Incorporated
6.13.1 Cargill Incorporated Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.13.2 Cargill Incorporated Orally Disintegrating Tablet Excipient Description, Business Overview and Total Revenue
6.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Cargill Incorporated Products Offered
6.13.5 Cargill Incorporated Recent Development
6.14 Daicel Corporation
6.14.1 Daicel Corporation Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.14.2 Daicel Corporation Orally Disintegrating Tablet Excipient Description, Business Overview and Total Revenue
6.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Daicel Corporation Products Offered
6.14.5 Daicel Corporation Recent Development
6.15 Anhui Sunhere Pharmaceutical
6.15.1 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Production Sites and Area Served
6.15.2 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Description, Business Overview and Total Revenue
6.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Anhui Sunhere Pharmaceutical Products Offered
6.15.5 Anhui Sunhere Pharmaceutical Recent Development
7 Orally Disintegrating Tablet Excipient Manufacturing Cost Analysis
7.1 Orally Disintegrating Tablet Excipient Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Orally Disintegrating Tablet Excipient
7.4 Orally Disintegrating Tablet Excipient Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Orally Disintegrating Tablet Excipient Distributors List
8.3 Orally Disintegrating Tablet Excipient Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Orally Disintegrating Tablet Excipient Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Orally Disintegrating Tablet Excipient by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Orally Disintegrating Tablet Excipient by Type (2021-2026)
10.2 Orally Disintegrating Tablet Excipient Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Orally Disintegrating Tablet Excipient by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Orally Disintegrating Tablet Excipient by Application (2021-2026)
10.3 Orally Disintegrating Tablet Excipient Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Orally Disintegrating Tablet Excipient by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Orally Disintegrating Tablet Excipient by Region (2021-2026)
10.4 North America Orally Disintegrating Tablet Excipient Estimates and Projections (2021-2026)
10.5 Europe Orally Disintegrating Tablet Excipient Estimates and Projections (2021-2026)
10.6 Asia Pacific Orally Disintegrating Tablet Excipient Estimates and Projections (2021-2026)
10.7 Latin America Orally Disintegrating Tablet Excipient Estimates and Projections (2021-2026)
10.8 Middle East and Africa Orally Disintegrating Tablet Excipient Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Orally Disintegrating Tablet Excipient Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Orally Disintegrating Tablet Excipient Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Orally Disintegrating Tablet Excipient Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Orally Disintegrating Tablet Excipient Manufacturers Covered in This Study
Table 5. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Orally Disintegrating Tablet Excipient Sales Share by Manufacturers (2015-2020)
Table 7. Global Orally Disintegrating Tablet Excipient Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Orally Disintegrating Tablet Excipient Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Orally Disintegrating Tablet Excipient Sales Sites and Area Served
Table 11. Manufacturers Orally Disintegrating Tablet Excipient Product Types
Table 12. Global Orally Disintegrating Tablet Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Orally Disintegrating Tablet Excipient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orally Disintegrating Tablet Excipient as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Orally Disintegrating Tablet Excipient Players
Table 16. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Region (2015-2020)
Table 17. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2015-2020)
Table 18. Global Orally Disintegrating Tablet Excipient Revenue (Million US$) by Region (2015-2020)
Table 19. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2015-2020)
Table 20. North America Orally Disintegrating Tablet Excipient Sales by Country (2015-2020) (K MT)
Table 21. North America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2015-2020)
Table 22. North America Orally Disintegrating Tablet Excipient Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2015-2020)
Table 24. Europe Orally Disintegrating Tablet Excipient Sales by Country (2015-2020) (K MT)
Table 25. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country (2015-2020)
Table 26. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2015-2020)
Table 32. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2015-2020) (K MT)
Table 33. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2015-2020)
Table 34. Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2015-2020)
Table 40. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Type (2015-2020)
Table 41. Global Orally Disintegrating Tablet Excipient Sales Share by Type (2015-2020)
Table 42. Global Orally Disintegrating Tablet Excipient Revenue (Million US$) by Type (2015-2020)
Table 43. Global Orally Disintegrating Tablet Excipient Revenue Share by Type (2015-2020)
Table 44. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Type (2015-2020)
Table 45. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Application (2015-2020)
Table 46. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2015-2020)
Table 47. Global Orally Disintegrating Tablet Excipient Sales Growth Rate by Application (2015-2020)
Table 48. BASF Orally Disintegrating Tablet Excipient Corporation Information
Table 49. BASF Description and Business Overview
Table 50. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. BASF Main Product
Table 52. BASF Recent Development
Table 53. JRS Pharma Orally Disintegrating Tablet Excipient Corporation Information
Table 54. JRS Pharma Corporation Information
Table 55. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. JRS Pharma Main Product
Table 57. JRS Pharma Recent Development
Table 58. Roquette Orally Disintegrating Tablet Excipient Corporation Information
Table 59. Roquette Corporation Information
Table 60. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Roquette Main Product
Table 62. Roquette Recent Development
Table 63. ABF Ingredients Orally Disintegrating Tablet Excipient Corporation Information
Table 64. ABF Ingredients Corporation Information
Table 65. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. ABF Ingredients Main Product
Table 67. ABF Ingredients Recent Development
Table 68. DFE Pharma Orally Disintegrating Tablet Excipient Corporation Information
Table 69. DFE Pharma Corporation Information
Table 70. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. DFE Pharma Main Product
Table 72. DFE Pharma Recent Development
Table 73. Evonik Orally Disintegrating Tablet Excipient Corporation Information
Table 74. Evonik Corporation Information
Table 75. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Evonik Main Product
Table 77. Evonik Recent Development
Table 78. Merck KGaA Orally Disintegrating Tablet Excipient Corporation Information
Table 79. Merck KGaA Corporation Information
Table 80. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Merck KGaA Main Product
Table 82. Merck KGaA Recent Development
Table 83. Ashland Orally Disintegrating Tablet Excipient Corporation Information
Table 84. Ashland Corporation Information
Table 85. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Ashland Main Product
Table 87. Ashland Recent Development
Table 88. Meggle Pharma Orally Disintegrating Tablet Excipient Corporation Information
Table 89. Meggle Pharma Corporation Information
Table 90. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Meggle Pharma Main Product
Table 92. Meggle Pharma Recent Development
Table 93. Shin-Etsu Orally Disintegrating Tablet Excipient Corporation Information
Table 94. Shin-Etsu Corporation Information
Table 95. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Shin-Etsu Main Product
Table 97. Shin-Etsu Recent Development
Table 98. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Corporation Information
Table 99. Fuji Chemical Industries Corporation Information
Table 100. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Fuji Chemical Industries Main Product
Table 102. Fuji Chemical Industries Recent Development
Table 103. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Corporation Information
Table 104. McePharma (Vivesa holding) Corporation Information
Table 105. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. McePharma (Vivesa holding) Main Product
Table 107. McePharma (Vivesa holding) Recent Development
Table 108. Cargill Incorporated Orally Disintegrating Tablet Excipient Corporation Information
Table 109. Cargill Incorporated Corporation Information
Table 110. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Cargill Incorporated Main Product
Table 112. Cargill Incorporated Recent Development
Table 113. Daicel Corporation Orally Disintegrating Tablet Excipient Corporation Information
Table 114. Daicel Corporation Corporation Information
Table 115. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. Daicel Corporation Main Product
Table 117. Daicel Corporation Recent Development
Table 118. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Corporation Information
Table 119. Anhui Sunhere Pharmaceutical Corporation Information
Table 120. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. Anhui Sunhere Pharmaceutical Main Product
Table 122. Anhui Sunhere Pharmaceutical Recent Development
Table 123. Sales Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Orally Disintegrating Tablet Excipient Distributors List
Table 126. Orally Disintegrating Tablet Excipient Customers List
Table 127. Market Key Trends
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Global Orally Disintegrating Tablet Excipient Sales (K MT) Forecast by Type (2021-2026)
Table 131. Global Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Type (2021-2026)
Table 132. Global Orally Disintegrating Tablet Excipient Revenue (Million US$) Forecast by Type (2021-2026)
Table 133. Global Orally Disintegrating Tablet Excipient Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 134. Global Orally Disintegrating Tablet Excipient Sales (K MT) Forecast by Application (2021-2026)
Table 135. Global Orally Disintegrating Tablet Excipient Revenue (Million US$) Forecast by Application (2021-2026)
Table 136. Global Orally Disintegrating Tablet Excipient Sales (K MT) Forecast by Region (2021-2026)
Table 137. Global Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Region (2021-2026)
Table 138. Global Orally Disintegrating Tablet Excipient Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Global Orally Disintegrating Tablet Excipient Revenue Market Share Forecast by Region (2021-2026)
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Orally Disintegrating Tablet Excipient
Figure 2. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type: 2020 VS 2026
Figure 3. Binders Product Picture
Figure 4. Glidents Product Picture
Figure 5. Diluents Product Picture
Figure 6. Disintegrants Product Picture
Figure 7. Others Product Picture
Figure 8. Global Orally Disintegrating Tablet Excipient Consumption Market Share by Application: 2020 VS 2026
Figure 9. Anti-Psychotics Drug
Figure 10. Anti-Epileptics Drug
Figure 11. Others
Figure 12. Global Orally Disintegrating Tablet Excipient Market Size 2015-2026 (US$ Million)
Figure 13. Global Orally Disintegrating Tablet Excipient Sales Capacity (K MT) (2015-2026)
Figure 14. Global Orally Disintegrating Tablet Excipient Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Orally Disintegrating Tablet Excipient Sales Share by Manufacturers in 2020
Figure 16. Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Orally Disintegrating Tablet Excipient Revenue in 2019
Figure 18. Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2015-2020)
Figure 20. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region in 2019
Figure 21. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2015-2020)
Figure 22. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region in 2019
Figure 23. North America Orally Disintegrating Tablet Excipient Sales Market Share by Country in 2019
Figure 24. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Country in 2019
Figure 25. U.S. Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 26. U.S. Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 28. Canada Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country in 2019
Figure 30. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Country in 2019
Figure 31. Germany Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 32. Germany Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 34. France Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.K. Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 38. Italy Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 40. Russia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Region in 2019
Figure 42. Asia Pacific Orally Disintegrating Tablet Excipient Revenue Market Share by Region in 2019
Figure 43. China Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 44. China Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 46. Japan Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 48. South Korea Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 50. India Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 52. Australia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 54. Taiwan Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 56. Indonesia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 58. Thailand Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 60. Malaysia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 62. Philippines Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 64. Vietnam Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Country in 2019
Figure 66. Latin America Orally Disintegrating Tablet Excipient Revenue Market Share by Country in 2019
Figure 67. Mexico Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 68. Mexico Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 70. Brazil Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Orally Disintegrating Tablet Excipient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Country in 2019
Figure 75. Turkey Orally Disintegrating Tablet Excipient Sales Growth Rate (2015-
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs